Medications & Psychiatry

 email page    print page

All Topic Reviews
Psychiatry Under the InfluenceAlternatives Beyond PsychiatryAmerican MadnessAmerican PsychosisAn Unquiet MindAntipsychiatryBad PharmaBefore ProzacBetter Than ProzacBiological PsychiatryBipolar, Not So MuchBlack Man in a White CoatBlaming the BrainBrain Science and Psychological DisordersBrainwashedClinical Psychopharmacology Made Ridiculously SimpleComfortably NumbCompassion and Healing in Medicine and SocietyComplete Mental HealthConcise Guide to PsychopharmacologyCrackedCritical PsychiatryCultural FormulationDeconstructing PsychosisDemystifying PsychiatryDiagnosing the Diagnostic and Statistical Manual of Mental DisordersDiagnosis: SchizophreniaDiagnostic Issues in Depression and Generalized Anxiety DisorderDimensional Models of Personality DisordersDisordered Personalities and CrimeDoctoring the MindDoctors of DeceptionDrop the Disorder!DruggedDrugs for LifeEmpirical Ethics in PsychiatryEssential PsychopharmacologyEssential Psychopharmacology of Depression and Bipolar DisorderEssentials of Psychiatric DiagnosisEsssential Philosophy of PsychiatryEthics in PsychiatryEvidence-Based Treatment of Personality DysfunctionExercise-Based Interventions for Mental IllnessFinding the Right Psychiatrist:Forces of HabitHandbook of Clinical Psychopharmacology for TherapistsHappy Pills in AmericaHealing the Soul in the Age of the BrainHelping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional ProblemsHerbs for the MindHigh PriceHippocrates CriedHistory of Psychiatry and Medical PsychologyHookedHuman TrialsInfectious MadnessInspired SleepIntoxicating MindsIs It Me or My Meds?Let Them Eat ProzacLife-Threatening Effects of Antipsychotic DrugsLitLiving with Bipolar DisorderMad in AmericaMad ScienceMalignant SadnessMedicating ChildrenMedicating Modern AmericaMental Health in Asia and the PacificMind FixersMoments of EngagementMommy I'm Still in HereNatural Healing for DepressionNo One Cares About Crazy PeopleNot CrazyOrdinarily WellOur Daily MedsOverdosed AmericaPathologist of the MindPediatric PsychopharmacologyPediatric PsychopharmacologyPediatric PsychopharmacologyPharmaceutical FreedomPharmacracyPharmageddonPharmageddonPhilosophical Issues in PharmaceuticsPoets on ProzacPower HerbsPowerful MedicinesPrescriptions for the MindProfits Before People?Prozac and the New AntidepressantsProzac As a Way of LifeProzac BacklashProzac DiaryProzac on the CouchPsychiatric DiagnosisPsychiatric HegemonyPsychiatrists and Traditional HealersPsychiatry and EmpirePsychiatry and the Business of MadnessPsychiatry as Cognitive NeurosciencePsychiatry at a GlancePsychiatry in PrisonsPsychiatry ReconsideredPsychopathyPsychopharmacology Problem SolvingPsychotropic Drug Prescriber's Survival GuidePsychotropic Drugs And Popular CulturePsychotropic Drugs: Fast FactsRaising Generation RxRe-Visioning PsychiatryRecovery from SchizophreniaReligious and Spiritual Issues in Psychiatric DiagnosisRitalin NationRunning on RitalinRutter's Child and Adolescent PsychiatrySaving NormalSchizophreniaShock TherapyShock TherapyShould I Medicate My Child?ShrinksSide EffectsSometimes Amazing Things HappenStraight Talk about Psychiatric Medications for KidsSuccessful PsychopharmacologySuffer the ChildrenTaking America Off DrugsTalking Back to ProzacTextbook of Cultural PsychiatryThe $800 Million PillThe Age of AnxietyThe Anti-Depressant Fact BookThe Antidepressant EraThe Antidepressant SolutionThe Antidepressant Survival ProgramThe Big FixThe Book of WoeThe Complete Guide to Herbal MedicinesThe Conceptual Evolution of DSM-5The CorrectionsThe Creation of PsychopharmacologyThe Cult of PharmacologyThe Dream DrugstoreThe Emperor's New DrugsThe Essential Guide to Prescription Drugs 2005The Essential Guide to Prescription Drugs 2006The Making of DSM-III®The Medical Model in Mental HealthThe Medicated ChildThe Medication QuestionThe Merck DruggernautThe Mind/Mood Pill BookThe Natural Pharmacist : Natural Health Bible from the Most Trusted Alternative Health Site in the World The Pill BookThe Pill Book Guide to Natural MedicinesThe PlaceboThe Rise and Fall of the Biopsychosocial ModelThe Sedated SocietyThe Therapist's Guide to PsychopharmacologyThe Therapist's Guide to Psychopharmacology, Revised EditionThe Truth About the Drug CompaniesThe Use and Misuse of Psychiatric DrugsThe World of CaffeineThomas S. SzaszToxic PsychiatryTrouble in MindTry to RememberTry to RememberTwilight of American SanityUnderstanding Physician-Pharmaceutical Industry InteractionsUnhingedVoluntary MadnessWarning: Psychiatry Can Be Hazardous to Your Mental HealthWhat Is Mental Illness?What Psychiatry Left Out of the DSM-5What Works for Whom?Will@epicqwest.comWomen, Madness and MedicineYour Drug May Be Your Problem

Related Topics
PharmageddonReview - Pharmageddon
by David Healy
University of California Press, 2012
Review by E. James Lieberman
Mar 11th 2014 (Volume 18, Issue 11)


A psychiatrist, pharmacologist and medical historian who trained in Dublin and Cambridge, David Healy invokes Armageddon, the final battle between good and evil, to portray the current--hopefully not permanent--domination of medicine by a huge for-profit industry. Until the 1970s, medical tests and pharmaceuticals mainly targeted life-threatening diseases. Since then chronic disease management has been the growing focus. Drugs modify risk and lifestyle factors because that's where the money is, not because the results are good. A century ago "patent medicine" was not a term of respect; the science of pharmacy is tainted by selective reporting of research, advertising to consumers, and coddling physicians. 

The ten top-selling drugs do relatively little good but account for $60 billion in annual sales. These "blockbusters" rose from 6% of the market in 1991 to 45% in 2006: "the big money now lies in marketing chronic diseases for which the current best selling drugs in medicine offer little benefit." (10)  Consider the recent invention of "Low-T." Levels of testosterone normally decline with age and there is no evidence that raising them will do more good than harm. Television advertising of prescription drugs enriches our media; for good reason, direct-to-consumer ads of pharmaceuticals are illegal everywhere except the U.S. and New Zealand. 

On-patent drugs greatly increase the cost of health care but doctors spend even more on remedying problems caused by drugs! (p. 11) Our concerns with lowering cholesterol, blood pressure, etc., lead Americans to spend far more on chronic prevention, as it were, than people in other countries who are healthier without it. Pharmaceutical companies learned their ad approach from purveyors of turn-of-the century patent medicines--quacks. Nowadays the same techniques persuade millions to buy bottled water and treatments for invented conditions like "Low-T" and "overactive bladder." In the 1960s, "magic bullets" like Penicillin, anti-hypertension and antipsychotic drugs did not need advertising, but the scene was set because they were available by prescription only and profits mounted with "the emergence of blockbuster branding in the 1980s." (26)

Doctors want to practice evidence-based medicine, which the pharmaceutical industry also advocates. The problem comes from the way those companies tweak the evidence. The Food and Drug Administration (FDA) is permissive judge. Only two statistically significant trials of a new drug will pass muster with the FDA, though there may be 98 misses! Healy's critique concerns the lack of access to basic data in drug trials. The FDA accepts findings that appear positive, but allow the drug company to list deaths as dropouts rather than as victims of the experiment. Negative results with new drugs need not be published, while many favorable ghost-written reports appear in respected journals under the names of researchers. Small differences between placebo and a medication on trial can become statistically significant without being clinically significant. Beating the placebo is not difficult; in clinical trials SSRIs were no better than older antidepressants but that comparison is not published. Journals hesitate to carry critical articles about new drugs because they may be sued. New drugs without real merit have repeatedly been made into best-sellers by physicians who don't understand how the system really works. As a result we pay twice as much for medical care that is only half as good as that of dozens of other nations, while untoward side effects of "successful" drugs decrease life expectancy here compared with other developed nations. 

Ambiguities in psychiatric classification invite promotion of a single drug for both anxiety and depression. After the tranquilizers Valium and Librium came the SSRIs--selective serotonin reuptake inhibitors--in the 1990s. Some earlier antidepressants had an effect on the neurotransmitter serotonin and the SSRIs were no more selective than some older drugs!  Depakote was approved by the FDA for the manic pole of manic-depressive illness. Abbott, its maker, could not legally say it prevented mood swings, so the term "mood stabilizer," which has no precise meaning, served as an advertising term (like tranquilizer and SSRI). Meanwhile manic-depressive illness, a rare and serious ailment affecting ten people per million, was renamed "bipolar disorder," a milder illness treatable in outpatients that affected 50,000 per million. Many doctors were persuaded that these patients were better served with prescriptions for costly mood stabilizers (Zyprexa, Seroquel) rather than equally effective and cheaper tranquilizers and antidepressants.

It takes a keen historian with expert knowledge of pharmacy and finance to explain the drugging of America so clearly, as Erectile Disfunction replaced impotence, boisterousness was labelled Attention Deficit Hyperactivity Disorder, and anxiety morphed into panic. "Disorders that were once defined by patients' needs for medical services and doctors' perceptions of their pathology are now increasingly defined by the goals of marketeers." (38). Bipolar disorder and osteoporosis, formerly rare, became common. Medicine changed "from a profession deeply hostile to marketing into a marketer's dream." (39)  Healy analyzes marketing practices, fine-tuned instruments used on consumers at one level and doctors at another. "The normal elevations of blood lipids and thinning bones that go with age are transformed into diseases...subject to fashion with the main determinant of the fashion cycle being the patent life of the drug." (60)

Cholesterol has created a huge market; Lipitor made $12 billion in sales in 2008. Ads say it reduces the threat of heart attack by 36 percent. Typically this can be supported by a study in which three percent of men at risk and on placebo have a heart attack compared with two percent on the drug. This is a 50 percent reduction in relative (not absolute) risk. Patients and doctors alike may know this and still not appreciate that the reduction does not apply to people without a history of heart disease. Healy states that using pills to reduce cholesterol appears to increase mortality. Osteoporosis, another vogue, began in 1988, proclaiming normal bone thinning in women as treatable disease. (172) The "health products market" seems to have replaced the practice of medicine. "No pharmaceutical company is ever likely to provide a scanner, meter, or rating scale for medical care that focuses on the person rather than a disease." (191)

Healy has a broad historical perspective on the tools and ethics of medicine. French psychiatrist Phillipe Pinel (1745-1826), who opposed the growth of polypharmacy in his time, wins praise as a pioneer in diagnosis, humane treatment and prognosis. Also lauded is Frances Kelsey, whose FDA review in 1960 kept thalidomide from damaging countless fetuses. She noted inadequate testing and resisted corporate pressure. "When it came to drugs, the management of pregnancy became the one area of medicine that most closely conform to Pinel's hope for all medicine--that doctors in knowing when not to prescribe would demonstrate the highest medical art. Many think this still is the case but today's reality is quite different" (43)

I am not alone in the opinion that if you have to ask your doctor for an advertised drug, you need a new doctor. When I was in medical school it was unethical for doctors and hospitals to advertise. Newer often is worse, not better. One should wait until a drug has been on the market for several years before assuming it is safe: side effects emerge as time goes on. FDA approval is less a green light than a flashing yellow. First users of new prescription drugs are part of a very large unofficial experiment. We owe respect to David Healy for his knowledge, diligence and idealism. This and his other writings require expertise and courage. He knows he is an underdog in this battle and fights on for the benefit of patients and the medical profession itself. More power to you, Doctor Healy!



© 2014 E. James Lieberman



E. James Lieberman is Clinical Professor of Psychiatry emeritus, George Washington University, and co-editor of The Letters of Sigmund Freud and Otto Rank: Inside Psychoanalysis (2012).


Welcome to Metapsychology.

Note that Metapsychology will be moving to a new server in January 2020. We will not put up new reviews during the transition. We thank you for your support and look forward to coming back with a revised format.

We feature over 8300 in-depth reviews of a wide range of books and DVDs written by our reviewers from many backgrounds and perspectives. We update our front page weekly and add more than twenty new reviews each month. Our editor is Christian Perring, PhD. To contact him, use one of the forms available here.

Metapsychology Online reviewers normally receive gratis review copies of the items they review.
Metapsychology Online receives a commission from for purchases through this site, which helps us send review copies to reviewers. Please support us by making your purchases through our Amazon links. We thank you for your support!

Join our Google Group!

Interested in becoming a book reviewer for Metapsychology? To apply, write to our editor.

Metapsychology Online Reviews

Promote your Page too

Metapsychology Online Reviews
ISSN 1931-5716